| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insight Molecular Diagnostics Inc. (IMDX) has 7 insiders with recent SEC Form 4 filings, including 12 buys and 4 sells. IMDX is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 12.68M | $69.01M | - | |
| CEO | 400.0K | $2.18M | - | |
| CFO | 201.2K | $1.09M | - | |
| Dir | 136.6K | $742.9K | - | |
| Dir | 39.5K | $214.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2021 | Broadwood Partners, L.P.60 | 10% Owner | Buy | 600,000 | $4.50 | $2,700,000.00 | +1.8% | |
| Jan 20, 2021 | Broadwood Partners, L.P.60 | 10% Owner | Buy | 1,460,280 | $3.42 | $4,999,998.72 | +4.7% | |
| Dec 23, 2020 | Kingsley Alfred D | - | Sale+OE | 900 | $2.55 | $2,295.00 | -0.3% | |
| Dec 22, 2020 | Kingsley Alfred D | - | Sale+OE | 42,800 | $0.31 | $13,075.92 | -4.3% | |
| Aug 3, 2020 | Andrews Ronald Asbury | Chief Executive Officer | Buy | 40,000 | $1.35 | $53,880.00 | +63.8% | |
| Aug 3, 2020 | Parker Albert P | Chief Operating Officer | Buy | 5,000 | $1.33 | $6,648.00 | New | |
| Aug 3, 2020 | Kalajian Tony T | Sr.vp/ Chief Accounting Officer | Buy | 5,000 | $1.31 | $6,533.00 | +50.0% | |
| Aug 3, 2020 | Levine Mitchell S | Chief Financial Officer | Buy | 10,000 | $1.32 | $13,200.00 | +37.6% | |
| Apr 24, 2020 | Broadwood Partners, L.P.60 | 10% Owner | Buy | 1,050,000 | $2.27 | $2,383,500.00 | +3.7% | |
| Mar 31, 2020 | Andrews Ronald Asbury | CEO And President | Buy | 45,216 | $945.63 | $42,757,453.73 | +72.7% |